NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,812.90+₹51.90 (+2.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.48% below the high.
Loading market information…
BSE · GANGAPHARM.BO · INR
Stock price
Quote as of Sep 10, 2026, 02:49 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Ganga Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 14.38% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Ganga Pharmaceuticals Ltd. is actively involved in the production and trade of pharmaceutical products and related goods. The company primarily concentrates on the formulation, marketing, and supply of Ayurvedic medicines in bulk quantities. Notable products in its portfolio include Ampachan Vati, Khadira Vati, and Nirmalaya Churna. The firm offers a range of Ayurvedic solutions designed to address health issues such as acidity, dandruff, oxidative stress, constipation, oral hygiene, diarrhea, ear ailments, women's health, and joint discomfort. Brijmohan C. Sharma founded the organization in 1974, and its main corporate office is located in Mumbai, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:21 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,812.90+₹51.90 (+2.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.48% below the high.
₹9,811.00+₹147.00 (+1.52%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 0.35% below the high.
₹4,641.80+₹61.80 (+1.35%)
Torrent Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 11.68% below the high.
₹2,371.00+₹127.00 (+5.66%)
Laurus Labs Limited’s quoted price sits in the upper half of its reported 52-week range, 0.48% below the high.
₹1,241.30+₹56.90 (+4.8%)
Zydus Lifesciences Limited’s quoted price sits in the upper half of its reported 52-week range, 0.59% below the high.
₹8,310.00+₹110.00 (+1.34%)
Apollo Hospitals Enterprise Limited’s quoted price sits in the upper half of its reported 52-week range, 8.36% below the high.
₹682.20+₹0.45 (+0.07%)
Lenskart Solutions Limited’s quoted price sits in the upper half of its reported 52-week range, 5.9% below the high.
₹1,359.10+₹14.10 (+1.05%)
Dr. Reddy's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 4.05% below the high.
